Canada · Delayed Price · Currency is CAD CareRx Statistics
Total Valuation
CareRx has a market cap or net worth of CAD 230.39 million. The enterprise value is 297.15 million.
| Market Cap | 230.39M |
| Enterprise Value | 297.15M |
Important Dates
The last earnings date was Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
CareRx has 63.47 million shares outstanding. The number of shares has increased by 5.06% in one year.
| Current Share Class | 63.47M |
| Shares Outstanding | 63.47M |
| Shares Change (YoY) | +5.06% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 1.55% |
| Owned by Institutions (%) | 27.44% |
| Float | 34.16M |
Valuation Ratios
The trailing PE ratio is 8.66 and the forward PE ratio is 18.00.
| PE Ratio | 8.66 |
| Forward PE | 18.00 |
| PS Ratio | 0.61 |
| PB Ratio | 2.10 |
| P/TBV Ratio | 25.20 |
| P/FCF Ratio | 9.33 |
| P/OCF Ratio | 7.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.20, with an EV/FCF ratio of 12.03.
| EV / Earnings | 11.06 |
| EV / Sales | 0.79 |
| EV / EBITDA | 10.20 |
| EV / EBIT | 26.66 |
| EV / FCF | 12.03 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.08 |
| Quick Ratio | 0.70 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 2.62 |
| Debt / FCF | 3.09 |
| Interest Coverage | 1.78 |
Financial Efficiency
Return on equity (ROE) is 27.34% and return on invested capital (ROIC) is 7.05%.
| Return on Equity (ROE) | 27.34% |
| Return on Assets (ROA) | 3.34% |
| Return on Invested Capital (ROIC) | 7.05% |
| Return on Capital Employed (ROCE) | 6.13% |
| Weighted Average Cost of Capital (WACC) | 7.28% |
| Revenue Per Employee | 254,076 |
| Profits Per Employee | 18,119 |
| Employee Count | 1,533 |
| Asset Turnover | 1.63 |
| Inventory Turnover | 14.44 |
Taxes
| Income Tax | -22.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.82% in the last 52 weeks. The beta is 0.60, so CareRx's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +27.82% |
| 50-Day Moving Average | 3.35 |
| 200-Day Moving Average | 3.61 |
| Relative Strength Index (RSI) | 71.04 |
| Average Volume (20 Days) | 8,392 |
Short Selling Information
The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 865 |
| Short Previous Month | 1,548 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CareRx had revenue of CAD 376.80 million and earned 26.87 million in profits. Earnings per share was 0.42.
| Revenue | 376.80M |
| Gross Profit | 113.14M |
| Operating Income | 12.34M |
| Pretax Income | 4.85M |
| Net Income | 26.87M |
| EBITDA | 29.14M |
| EBIT | 11.15M |
| Earnings Per Share (EPS) | 0.42 |
Balance Sheet
The company has 9.57 million in cash and 76.34 million in debt, with a net cash position of -66.76 million or -1.05 per share.
| Cash & Cash Equivalents | 9.57M |
| Total Debt | 76.34M |
| Net Cash | -66.76M |
| Net Cash Per Share | -1.05 |
| Equity (Book Value) | 109.60M |
| Book Value Per Share | 1.73 |
| Working Capital | 4.70M |
Cash Flow
In the last 12 months, operating cash flow was 30.29 million and capital expenditures -5.59 million, giving a free cash flow of 24.70 million.
| Operating Cash Flow | 30.29M |
| Capital Expenditures | -5.59M |
| Depreciation & Amortization | 11.72M |
| Net Borrowing | -11.57M |
| Free Cash Flow | 24.70M |
| FCF Per Share | 0.39 |
Margins
Gross margin is 30.03%, with operating and profit margins of 3.27% and 7.13%.
| Gross Margin | 30.03% |
| Operating Margin | 3.27% |
| Pretax Margin | 1.29% |
| Profit Margin | 7.13% |
| EBITDA Margin | 7.73% |
| EBIT Margin | 2.96% |
| FCF Margin | 6.56% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.20%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 2.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 14.09% |
| Buyback Yield | -5.06% |
| Shareholder Yield | -2.81% |
| Earnings Yield | 11.66% |
| FCF Yield | 10.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for CareRx is 5.14, which is 41.60% higher than the current price. The consensus rating is "Buy".
| Price Target | 5.14 |
| Price Target Difference | 41.60% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 4.21% |
| EPS Growth Forecast (3Y) | 46.79% |
Stock Splits
The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
CareRx has an Altman Z-Score of 1.2 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.2 |
| Piotroski F-Score | 6 |